CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the 2010 Deutsche Bank BioFEST on Wednesday, December 15, 2010 at 1:05 p.m. ET at the Four Seasons Hotel Boston.
